$2.39
0.42% today
Nasdaq, Feb 28, 08:17 pm CET
ISIN
US5560991094
Symbol
MGNX
Sector
Industry

MacroGenics, Inc. Target price 2025 - Analyst rating & recommendation

MacroGenics, Inc. Classifications & Recommendation:

Buy
40%
Hold
60%

MacroGenics, Inc. Price Target

Target Price $6.17
Price $2.40
Potential
Number of Estimates 6
6 Analysts have issued a price target MacroGenics, Inc. 2026 . The average MacroGenics, Inc. target price is $6.17. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 4 Analysts recommend MacroGenics, Inc. to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the MacroGenics, Inc. stock has an average upside potential 2026 of . Most analysts recommend the MacroGenics, Inc. stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 58.75 162.16
61.33% 176.02%
Net Margin -16.02% -45.71%
80.11% 185.26%

8 Analysts have issued a sales forecast MacroGenics, Inc. 2024 . The average MacroGenics, Inc. sales estimate is

$162m
Unlock
. This is
14.74% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$189m 33.87%
Unlock
, the lowest is
$133m 5.89%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $58.8m 61.33%
2024
$162m 176.02%
Unlock
2025
$69.9m 56.87%
Unlock
2026
$88.7m 26.86%
Unlock
2027
$76.4m 13.86%
Unlock
2028
$120m 57.14%
Unlock

9 MacroGenics, Inc. Analysts have issued a net profit forecast 2024. The average MacroGenics, Inc. net profit estimate is

$-74.1m
Unlock
. This is
24.77% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$0.0 100.00%
Unlock
, the lowest is
$-112m 14.01%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-9.4m 92.31%
2024
$-74.1m 687.44%
Unlock
2025
$-144m 93.88%
Unlock
2026
$-116m 19.55%
Unlock
2027
$-145m 25.52%
Unlock
2028
$-146m 0.47%
Unlock

Net Margin

2023 -16.02% 80.11%
2024
-45.71% 185.26%
Unlock
2025
-205.50% 349.57%
Unlock
2026
-130.32% 36.58%
Unlock
2027
-189.90% 45.72%
Unlock
2028
-121.42% 36.06%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.15 -1.18
92.31% 686.67%
P/E negative
EV/Sales negative

9 Analysts have issued a MacroGenics, Inc. forecast for earnings per share. The average MacroGenics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.18
Unlock
. This is
24.84% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.00 100.00%
Unlock
, the lowest is
$-1.79 14.01%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.15 92.31%
2024
$-1.18 686.67%
Unlock
2025
$-2.29 94.07%
Unlock
2026
$-1.84 19.65%
Unlock
2027
$-2.31 25.54%
Unlock
2028
$-2.32 0.43%
Unlock

P/E ratio

Current -1.53 106.73%
2024
-2.03 32.68%
Unlock
2025
-1.05 48.28%
Unlock
2026
-1.30 23.81%
Unlock
2027
-1.04 20.00%
Unlock
2028
-1.03 0.96%
Unlock

Based on analysts' sales estimates for 2024, the MacroGenics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

-0.10
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -0.11 101.48%
2024
-0.10 12.36%
Unlock
2025
-0.22 131.85%
Unlock
2026
-0.18 21.16%
Unlock
2027
-0.20 16.06%
Unlock
2028
-0.13 36.33%
Unlock

P/S ratio

Current 1.07 88.53%
2024
0.93 12.84%
Unlock
2025
2.15 131.87%
Unlock
2026
1.70 21.17%
Unlock
2027
1.97 16.09%
Unlock
2028
1.25 36.36%
Unlock

Current MacroGenics, Inc. Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JMP Securities Locked ➜ Locked Locked Nov 07 2024
HC Wainwright & Co. Locked ➜ Locked Locked Nov 06 2024
HC Wainwright & Co. Locked ➜ Locked Locked Sep 18 2024
HC Wainwright & Co. Locked ➜ Locked Locked Aug 21 2024
Analyst Rating Date
Locked
JMP Securities: Locked ➜ Locked
Nov 07 2024
Locked
HC Wainwright & Co.: Locked ➜ Locked
Nov 06 2024
Locked
HC Wainwright & Co.: Locked ➜ Locked
Sep 18 2024
Locked
HC Wainwright & Co.: Locked ➜ Locked
Aug 21 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today